Announcements
Investor News
BioPorto A/S
Unlocking the Growth - Invitation to BioPorto’s investor meeting on Oct 7
Mon, 14 Sep 2026 12:55 GMT
BioPorto A/S
BioPorto announces Interim Results for the Second Quarter and First half of 2026
Thu, 20 Aug 2026 05:55 GMT
BioPorto A/S
BioPorto annoncerer resultat for andet kvartal og første halvår af 2026
Thu, 20 Aug 2026 05:55 GMT
BioPorto A/S
BioPorto activates the first US clinical site as part of the ProNephro AKI® U.S. Adult Urine NGAL Validation Study.
Tue, 18 Aug 2026 12:53 GMT
BioPorto A/S
BioPorto aktiverer det første deltagende hospital i USA som led i Selskabets ProNephro AKI® U.S. voksen urin validerings studie.
Tue, 18 Aug 2026 12:53 GMT